To Tweet Or Not To Tweet? Social Media Marketing Guidance Is There If You Look For It, Experts Say
This article was originally published in The Gray Sheet
Executive Summary
Device and drug firms waiting for FDA to issue guidance on how best to use social media for marketing and promotion can look instead at existing regulations both in and outside the agency, experts said recently.
You may also be interested in...
Third-Party Social Media: Firms Should Not Be Selective In Corrections
FDA’s draft guidance on correcting independent third-party misinformation about drugs and devices advises companies to address exaggerated efficacy claims as well as incorrect risk information.
FDA Should Loosen Leash On Responding To Off-Label Info Requests, Industry Says
The standard in a recent FDA draft guidance for how companies should respond to unsolicited public requests for off-label product information is too restrictive, firms say.
Off-Label Questions, Online: FDA Explains How To Handle Them
FDA draft guidance weighs in on web communications, saying that firms must answer off-label-information questions privately, even if the questions arise in a public online forum.